MAZZAGLIA GIAMPIERO

Antonazzo, I., Fornari, C., Buongarzone, G., Ferrara, P., Crotti, G., Zucchi, A., et al. (2026). Anti-seizure medications in patients with post-stroke epilepsy: A survival analysis study. EPILEPSIA, 67(2), 686-695 [10.1111/epi.18706]. Detail

Antonazzo, I., Fornari, C., Zamparini, M., Crotti, G., Zucchi, A., Ferrara, P., et al. (2026). Changes in youth public psychiatric service utilization during the COVID-19 pandemic in Italy: an observational study. FRONTIERS IN PHARMACOLOGY, 17 [10.3389/fphar.2026.1708009]. Detail

Ferrara, P., Rozza, D., Antonazzo, I., Zamparini, M., Ferrari, E., Palladino, P., et al. (2025). Awareness and management of stage 3 chronic kidney disease among primary care practitioners in Italy: a nation-wide observational study. JN. JOURNAL OF NEPHROLOGY, 38(9), 2731-2742 [10.1007/s40620-025-02384-5]. Detail

Antonazzo, I., Rozza, D., Cortesi, P., Fornari, C., Zanzottera Ferrari, E., Paris, C., et al. (2025). Generalizability and treatment with sodium-glucose co-trasporter-2 inhibitors (SGLT2i) among patients with type 2 diabetes: an assessment using an Italian primary care database. ACTA DIABETOLOGICA, 62(3), 343-351 [10.1007/s00592-024-02359-1]. Detail

Ferrara, P., Rozza, D., Antonazzo, I., Zamparini, M., Losa, L., Ferrari, E., et al. (2025). MISSED OPPORTUNITIES IN THE DIAGNOSIS AND MANAGEMENT OF STAGE 3 CHRONIC KIDNEY DISEASE IN GENERAL PRACTICE: INSIGHTS FROM THE ITALIAN THIN DATABASE. VALUE IN HEALTH, 28(12 S1). Detail